{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:46:45Z","timestamp":1791924405835,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Department of Pathology, Stanford University School of Medicine"},{"name":"Kite pharma & california institute for regenerative medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare lymphoma with sparse tumor B-cells and a favorable prognosis. Variant growth patterns of NLPHL, however, often show advanced stage, progression to T-cell\/histiocyte-rich large B-cell lymphoma (THRLBCL) and a worse prognosis. We studied the tumor microenvironment (TME) of NLPHL and THRLBCL using highplex imaging and spatial profiling at the single cell level. Our findings show distinct differences in TME composition and spatial configuration that differ among typical and variant NLPHL and THRLBCL. Typical NLPHL show abundant helper T-cell subsets, while THRLBCL show abundant cytotoxic T-cells and macrophages. Tumor B-cell size and content is lowest in typical NLPHL, followed by variant NLPHL, and highest in THRLBCL, whereas an opposite trend characterized TME B-cells. CD4\/CD8 double-positive T-cells are seen in all NLPHL but not in the majority of THRLBCL and are spatially distant from LP-cells and TFH-rosettes. The differences in macrophage\/monocyte content in distinguishing NLPHL pattern E from THRLBCL is further corroborated in independent cohorts of cases. Our results validate the current approach to classification and in addition provide novel insights that could be leveraged to refine clinical management for patients with this spectrum of lymphomas.<\/jats:p>","DOI":"10.1038\/s41408-024-01073-z","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T05:09:25Z","timestamp":1717132165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell\/histiocyte-rich large B-cell lymphoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Sheren","family":"Younes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7892-886X","authenticated-orcid":false,"given":"Ajay","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Binkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-1018","authenticated-orcid":false,"given":"Yasodha","family":"Natkunam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"1073_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001. Blood. 2006;107:265\u201376.","journal-title":"Blood"},{"key":"1073_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21357","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin 2016;66:443\u201359.","journal-title":"CA Cancer J Clin"},{"issue":"Jul","key":"1073_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(Jul):1720\u201348.","journal-title":"Leukemia"},{"key":"1073_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1200\/JCO.2009.24.9516","volume":"28","author":"M Al-Mansour","year":"2010","unstructured":"Al-Mansour M, Connors JM, Gascoyne RD, Skinnider B, Savage KJ. Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin\u2019s lymphoma. J Clin Oncol. 2010;28:793\u20139.","journal-title":"J Clin Oncol"},{"key":"1073_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/cncr.24819","volume":"116","author":"I Biasoli","year":"2010","unstructured":"Biasoli I, Stamatoullas A, Meignin V, Delmer A, Reman O, Morschhauser F, et al. Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group. Cancer. 2010;116:631\u20139.","journal-title":"Cancer"},{"key":"1073_CR6","doi-asserted-by":"publisher","first-page":"e78812","DOI":"10.1371\/journal.pone.0078812","volume":"8","author":"S Hartmann","year":"2013","unstructured":"Hartmann S, D\u00f6ring C, Jakobus C, Rengstl B, Newrzela S, Tousseyn T, et al. Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell\/Histiocyte Rich Large B Cell Lymphoma\u2014Endpoints of a Spectrum of One Disease? PLoS One. 2013;8:e78812.","journal-title":"PLoS One"},{"key":"1073_CR7","doi-asserted-by":"publisher","first-page":"E103","DOI":"10.1002\/ajh.23989","volume":"90","author":"TA Eyre","year":"2015","unstructured":"Eyre TA, Gatter K, Collins GP, Hall GW, Watson C, Hatton CS. Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: Long-term outcomes from a 30-year experience. Am J Hematol. 2015;90:E103\u2013E110.","journal-title":"Am J Hematol."},{"key":"1073_CR8","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1200\/JCO.2014.60.4363","volume":"33","author":"DA Eichenauer","year":"2015","unstructured":"Eichenauer DA, Pl\u00fctschow A, Fuchs M, von Tresckow B, B\u00f6ll B, Behringer K, et al. Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group. J Clin Oncol. 2015;33:2857\u201362.","journal-title":"J Clin Oncol"},{"key":"1073_CR9","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1182\/blood-2015-08-665505","volume":"127","author":"SS Kenderian","year":"2016","unstructured":"Kenderian SS, Habermann TM, Macon WR, Ristow KM, Ansell SM, Colgan JP, et al. Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution. Blood. 2016;127:1960\u20136.","journal-title":"Blood"},{"key":"1073_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/bjh.14518","volume":"177","author":"AG Shankar","year":"2017","unstructured":"Shankar AG, Roques G, Kirkwood AA, Lambilliotte A, Freund K, Leblanc T, et al. Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: Clinical characteristics and treatment outcome\u2014A report from the SFCE & CCLG groups. Br J Haematol. 2017;177:106\u201315.","journal-title":"Br J Haematol."},{"key":"1073_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27375","volume":"65","author":"LJ Marks","year":"2018","unstructured":"Marks LJ, Pei Q, Bush R, Buxton A, Appel B, Kelly KM, et al. Outcomes in intermediate-risk pediatric lymphocyte-predominant Hodgkin lymphoma: A report from the Children\u2019s Oncology Group. Pediatr Blood Cancer. 2018;65:e27375.","journal-title":"Pediatr Blood Cancer."},{"key":"1073_CR12","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1182\/blood.2019003877","volume":"135","author":"MS Binkley","year":"2020","unstructured":"Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang R, Dickinson M, et al. Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: A multi-institutional study of adult patients by ILROG. Blood. 2020;135:2365\u201374.","journal-title":"Blood"},{"key":"1073_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1200\/JCO.19.00986","volume":"38","author":"DA Eichenauer","year":"2020","unstructured":"Eichenauer DA, Pl\u00fctschow A, Fuchs M, Sasse S, Baues C, B\u00f6ll B, et al. Long-Term Follow-Up of Patients with Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group. J Clin Oncol. 2020;38:698\u2013705.","journal-title":"J Clin Oncol."},{"key":"1073_CR14","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.3324\/haematol.2021.278427","volume":"106","author":"L Paschold","year":"2021","unstructured":"Paschold L, Willscher E, Bein J, Vornanen M, Eichenauer DA, Simnica D, et al. Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation. Haematologica. 2021;106:2654\u201366.","journal-title":"Haematologica"},{"key":"1073_CR15","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","volume":"27","author":"Z Fan","year":"2003","unstructured":"Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA. Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol. 2003;27:1346\u201356.","journal-title":"Am J Surg Pathol"},{"key":"1073_CR16","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1182\/blood-2013-07-515825","volume":"19","author":"S Hartmann","year":"2013","unstructured":"Hartmann S, Eichenauer DA, Pl\u00fctschow A, Mottok A, Bob R, Koch K, et al. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood. 2013;19:4246\u201352.","journal-title":"Blood"},{"key":"1073_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pathol.2019.10.003","volume":"52","author":"S Hartmann","year":"2020","unstructured":"Hartmann S, Eichenauer DA. Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell\/histiocyte rich large B-cell lymphoma. Pathology. 2020;52:142\u201353.","journal-title":"Pathology"},{"key":"1073_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/ajcp\/aqab113","volume":"157","author":"D Xia","year":"2022","unstructured":"Xia D, Sayed S, Moloo Z, Gakinya SM, Mutuiri A, Wawire J, et al. Geographic variability of nodular lymphocyte-predominant Hodgkin Lymphoma. Am J Clin Pathol. 2022;157:231\u201343.","journal-title":"Am J Clin Pathol"},{"key":"1073_CR19","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1080\/10428190701559124","volume":"48","author":"A El Weshi","year":"2007","unstructured":"El Weshi A, Akhtar S, Mourad WA, Ajarim D, Abdelsalm M, Khafaga Y, et al. T-cell\/histiocyte-rich B-cell lymphoma: Clinical presentation, management and prognostic factors: Report on 61 patients and review of literature. Leuk Lymphoma. 2007;48:1764\u201373.","journal-title":"Leuk Lymphoma."},{"key":"1073_CR20","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1200\/JCO.2003.06.046","volume":"21","author":"R Bouabdallah","year":"2003","unstructured":"Bouabdallah R, Mounier N, Guettier C, Molina T, Ribrag V, Thieblemont C, et al. T-Cell\/Histiocyte-Rich Large B-Cell Lymphomas and Classical Diffuse Large B-Cell Lymphomas Have Similar Outcome After Chemotherapy: A Matched-Control Analysis. J Clin Oncol. 2003;21:1271\u20137.","journal-title":"J Clin Oncol."},{"key":"1073_CR21","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1182\/blood.V97.6.1845","volume":"97","author":"S Franke","year":"2001","unstructured":"Franke S, Wlodarska I, Maes B, Vandenberghe P, Delabie J, Hagemeijer A, et al. Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances. Blood. 2001;97:1845\u201353.","journal-title":"Blood"},{"key":"1073_CR22","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/S0002-9440(10)64462-8","volume":"161","author":"S Franke","year":"2002","unstructured":"Franke S, Wlodarska I, Maes B, Vandenberghe P, Achten R, Hagemeijer A, et al. Comparative genomic hybridization pattern distinguishes T-cell\/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin\u2019s lymphoma. Am J Pathol. 2002;161:1861\u20137.","journal-title":"Am J Pathol"},{"key":"1073_CR23","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2018.07.010","volume":"174","author":"Y Goltsev","year":"2018","unstructured":"Goltsev Y, Samusik N, Kennedy-Darling J, Bhate S, Hale M, Vazquez G, et al. Deep Profiling of Mouse Splenic Architecture With CODEX Multiplexed Imaging. Cell. 2018;174:968\u201381.","journal-title":"Cell"},{"key":"1073_CR24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","volume":"182","author":"CM Sch\u00fcrch","year":"2020","unstructured":"Sch\u00fcrch CM, Bhate SS, Barlow GL, Phillips DJ, Noti L, Zlobec I, et al. Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front. Cell. 2020;182:1341\u201359.e19.","journal-title":"Cell"},{"key":"1073_CR25","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1038\/s41467-021-26974-6","volume":"12","author":"D Phillips","year":"2021","unstructured":"Phillips D, Matusiak M, Gutierrez BR, Bhate SS, Barlow GL, Jiang S, et al. Immune Cell Topography Predicts Response to PD-1 Blockade in Cutaneous T Cell Lymphoma. Nat Commun. 2021;12:6721.","journal-title":"Nat Commun"},{"key":"1073_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687673","volume":"12","author":"D Phillips","year":"2021","unstructured":"Phillips D, Sch\u00fcrch CM, Khodadoust MS, Kim YH, Nolan GP, Jiang S. Highly Multiplexed Phenotyping of Immunoregulatory Proteins in the Tumor Microenvironment by CODEX Tissue Imaging. Front Immunol. 2021;12:687673.","journal-title":"Front Immunol"},{"key":"1073_CR27","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1084\/jem.20080809","volume":"205","author":"V Brune","year":"2008","unstructured":"Brune V, Tiacci E, Pfeil I, D\u00f6ring C, Eckerle S, van Noesel CJ, et al. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med. 2008;205:2251\u20132268.","journal-title":"J Exp Med"},{"key":"1073_CR28","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1038\/s41596-019-0206-y","volume":"14","author":"Z Du","year":"2019","unstructured":"Du Z, Lin JR, Rashid R, Maliga Z, Wang S, Aster JC, et al. Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging. Nat Protoc. 2019;14:2900\u201330.","journal-title":"Nat Protoc"},{"key":"1073_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/cyto.a.20825","volume":"77","author":"J Spidlen","year":"2010","unstructured":"Spidlen J, Moore W, Parks D, Goldberg M, Bray C, Bierre P, et al. Data File Standard for Flow Cytometry, version FCS 3.1. Cytom A. 2010;77:97\u2013100.","journal-title":"Cytom A"},{"key":"1073_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33:495\u2013502.","journal-title":"Nat Biotechnol"},{"key":"1073_CR31","doi-asserted-by":"crossref","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nature Biotechnol. 2018;36:411\u201320.","DOI":"10.1038\/nbt.4096"},{"key":"1073_CR32","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;177:1888\u2013902.","journal-title":"Cell."},{"key":"1073_CR33","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u201387.","journal-title":"Cell."},{"key":"1073_CR34","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1093\/ajcp\/aqx121.195","volume":"149","author":"X Zhang","year":"2018","unstructured":"Zhang X, Tsang P. 196 IMP3\/KOC1, a new immunohistochemical marker for differentiating classical Hodgkin Lymphoma and nodular lymphocyte predominant Hodgkin lymphoma from diffuse large B-Cell lymphoma. Am J Clin Pathol. 2018;149:S83\u2013S84.","journal-title":"Am J Clin Pathol"},{"key":"1073_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10321-z","volume":"22","author":"F Kosari","year":"2022","unstructured":"Kosari F, Bakhshi T, Ameli F, Mokhtari M. The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell\/Histiocyte-Rich large B-Cell lymphoma. BMC Cancer. 2022;22:1359.","journal-title":"BMC Cancer"},{"key":"1073_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/gcc.20214","volume":"44","author":"B Poppe","year":"2005","unstructured":"Poppe B, De Paepe P, Michaux L, Dastugue N, Bastard C, Herens C, et al. PAX5\/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements. Genes Chromosomes Cancer. 2005;44:218\u201323.","journal-title":"Genes Chromosomes Cancer"},{"key":"1073_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/bjh.13310","volume":"169","author":"S Hartmann","year":"2015","unstructured":"Hartmann S, D\u00f6ring C, Vucic E, Chan FC, Ennishi D, Tousseyn T, et al. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma. Br J Haematol. 2015;169:415\u201322.","journal-title":"Br J Haematol"},{"key":"1073_CR38","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/leu.2015.328","volume":"30","author":"S Hartmann","year":"2016","unstructured":"Hartmann S, Schuhmacher B, Rausch T, Fuller L, D\u00f6ring C, Weniger M, et al. Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. Leukemia. 2016;30:844\u201353.","journal-title":"Leukemia"},{"key":"1073_CR39","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1038\/s41375-020-0739-7","volume":"34","author":"JY Song","year":"2020","unstructured":"Song JY, Egan C, Bouska AC, Zhang W, Gong Q, Venkataraman G, et al. Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma. Leukemia. 2020;34:2238\u201342.","journal-title":"Leukemia"},{"key":"1073_CR40","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3324\/haematol.2018.203224","volume":"104","author":"B Schuhmacher","year":"2019","unstructured":"Schuhmacher B, Bein J, Rausch T, Benes V, Tousseyn T, Vornanen M, et al. JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell\/histiocyte-rich large B-cell lymphoma. Haematologica. 2019;104:330\u20137.","journal-title":"Haematologica"},{"key":"1073_CR41","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/ajh.25972","volume":"95","author":"J Bein","year":"2020","unstructured":"Bein J, Thurner L, Hansmann ML, Hartmann S. Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse. Am J Hematol. 2020;95:1495\u2013502.","journal-title":"Am J Hematol"},{"key":"1073_CR42","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/bjh.17362","volume":"193","author":"J Veldman","year":"2021","unstructured":"Veldman J, Alsada ZND, van den Berg A, Plattel WJ, Diepstra A, Visser L. Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma. Br J Haematol. 2021;193:506\u201314.","journal-title":"Br J Haematol"},{"key":"1073_CR43","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1097\/PAS.0b013e318165b0d6","volume":"32","author":"SH Nam-Cha","year":"2008","unstructured":"Nam-Cha SH, Roncador G, Sanchez-Verde L, Montes-Moreno S, Acevedo A, Dom\u00ednguez-Franjo P, et al. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol. 2008;32:1252\u20137.","journal-title":"Am J Surg Pathol"},{"key":"1073_CR44","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.humpath.2010.05.010","volume":"41","author":"HR Churchill","year":"2010","unstructured":"Churchill HR, Roncador G, Warnke RA, Natkunam Y. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis. Hum Pathol. 2010;41:1726\u201334.","journal-title":"Hum Pathol"},{"key":"1073_CR45","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3390\/ijms17122127","volume":"17","author":"L Visser","year":"2016","unstructured":"Visser L, Rutgers B, Diepstra A, van den Berg A, Sattarzadeh A. Characterization of the microenvironment of nodular lymphocyte predominant Hodgkin lymphoma. Int J Mol Sci. 2016;17:2127.","journal-title":"Int J Mol Sci"},{"key":"1073_CR46","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/intimm\/dxy050","volume":"30","author":"Y Mita","year":"2018","unstructured":"Mita Y, Kimura MY, Hayashizaki K, Koyama-Nasu R, Ito T, Motohashi S, et al. Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells. Int Immunol. 2018;30:559\u201367.","journal-title":"Int Immunol"},{"key":"1073_CR47","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.3390\/cancers13123021","volume":"13","author":"S Younes","year":"2021","unstructured":"Younes S, Rojansky RB, Menke JR, Gratzinger D, Natkunam Y. Pitfalls in the Diagnosis of Nodular Lymphocyte Predominant Hodgkin Lymphoma: Variant Patterns, Borderlines and Mimics. Cancers. 2021;13:3021.","journal-title":"Cancers"},{"key":"1073_CR48","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/pin.12357","volume":"65","author":"AE Eladl","year":"2015","unstructured":"Eladl AE, Satou A, Elsayed AA, Suzuki Y, Shimizu-Kohno K, Kato S, et al. Nodular lymphocyte predominant Hodgkin lymphoma: Clincopathological study of 25 cases from Japan with a reappraisal of tissue associated macrophages. Pathol Int. 2015;65:652\u201360.","journal-title":"Pathol Int"},{"key":"1073_CR49","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1158\/1078-0432.CCR-21-3140","volume":"28","author":"M Autio","year":"2022","unstructured":"Autio M, Leivonen SK, Br\u00fcck O, Karjalainen-Lindsberg ML, Pellinen T, Lepp\u00e4 S. Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment. Clin Cancer Res. 2022;28:781\u201392.","journal-title":"Clin Cancer Res"},{"key":"1073_CR50","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1182\/blood-2006-12-064360","volume":"110","author":"JM Chemnitz","year":"2007","unstructured":"Chemnitz JM, Eggle D, Driesen J, Classen S, Riley JL, Debey-Pascher S, et al. RNA fingerprints provide direct evidence for the inhibitory role of TGF and PD-1 on CD4 T cells in Hodgkin lymphoma. Blood. 2007;110:3226\u201333.","journal-title":"Blood"},{"key":"1073_CR51","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.3390\/cancers14143546","volume":"14","author":"A Vermare","year":"2022","unstructured":"Vermare A, Gu\u00e9rin MV, Peranzoni E, Bercovici N. Dynamic CD8+ T Cell Cooperation with Macrophages and Monocytes for Successful Cancer Immunotherapy. Cancers. 2022;14:3546.","journal-title":"Cancers"},{"key":"1073_CR52","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1080\/10428190802308728","volume":"49","author":"A Rahemtullah","year":"2008","unstructured":"Rahemtullah A, Harris NL, Dorn ME, Preffer FI, Hasserjian RP. Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma. Leuk Lymphoma. 2008;49:1870\u20138.","journal-title":"Leuk Lymphoma"},{"key":"1073_CR53","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/bjh.18376","volume":"199","author":"S Hartmann","year":"2022","unstructured":"Hartmann S, Soltani AS, Bankov K, Bein J, Hansmann ML, Rosenwald A, et al. Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma. Br J Hematol. 2022;199:382\u201391.","journal-title":"Br J Hematol"},{"key":"1073_CR54","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/s41379-022-01016-8","volume":"35","author":"A Sadeghi Shoreh Deli","year":"2022","unstructured":"Sadeghi Shoreh Deli A, Scharf S, Steiner Y, Bein J, Hansmann ML, Hartmann S. 3D analyses reveal T cells with activated nuclear features in T-cell\/histiocyte-rich large B-cell lymphoma. Mod Pathol. 2022;35:1431\u20138.","journal-title":"Mod Pathol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01073-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01073-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01073-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T06:06:13Z","timestamp":1717135573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01073-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1038\/s41408-024-01073-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3629195\/v1","asserted-by":"object"}]},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]},"assertion":[{"value":"18 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.Y. reports research funding from Kite Pharma and California Institute for Regenerative Medicine; Y.N. reports consultancy for Leica Biosystems and Roche Diagnostics, and research funding from Kite Pharma; AK performed the entire study while at Stanford and recently joined Akoya Biosciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}